TrialMovement disorders : official journal of the Movement Disorder Society2022

A Randomized, Double-Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease.

Olivier Rascol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.